相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contributions Of Public Health, Pharmaceuticals, And Other Medical Care To US Life Expectancy Changes, 1990-2015
Jason D. Buxbaum et al.
HEALTH AFFAIRS (2020)
Explaining The Slowdown In Medical Spending Growth Among The Elderly, 1999-2012
David M. Cutler et al.
HEALTH AFFAIRS (2019)
Association of Rotavirus Vaccination With the Incidence of Type 1 Diabetes in Children
Kirsten P. Perrett et al.
JAMA PEDIATRICS (2019)
Impact of abolishing prescription fees in Scotland on hospital admissions and prescribed medicines: an interrupted time series evaluation
Andrew James Williams et al.
BMJ OPEN (2018)
Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes — United States and Puerto Rico, 2000–2014
Nilka Rios Burrows et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care
Julia L. Marcus et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Impact of Increased Early Statin Administration on Ischemic Stroke Outcomes: A Multicenter Electronic Medical Record Intervention
Alexander C. Flint et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Disability weights for the Global Burden of Disease 2013 study
Joshua A. Salomon et al.
LANCET GLOBAL HEALTH (2015)
The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009
Frank R. Lichtenberg
ECONOMICS & HUMAN BIOLOGY (2014)
Mapping from the Health Assessment Questionnaire to the EQ-5D: The Impact of Different Algorithms on Cost-Effectiveness Results
Becky Pennington et al.
VALUE IN HEALTH (2014)
Use of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements
Robert B. Penfold et al.
Academic Pediatrics (2013)
The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999-2007
Frank R. Lichtenberg
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2013)
Disability in rheumatoid arthritis in the era of biological treatments
Eswar Krishnan et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Twenty-Two-Year Trends in Incidence of Myocardial Infarction, Coronary Heart Disease Mortality, and Case Fatality in 4 US Communities, 1987-2008
Wayne D. Rosamond et al.
CIRCULATION (2012)
Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983-2007
Grant H. Louie et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Incidence of Treatment for End-Stage Renal Disease Among Individuals With Diabetes in the US Continues to Decline
Nilka Rios Burrows et al.
DIABETES CARE (2010)
The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004
Frank R. Lichtenberg
ECONOMICS OF INNOVATION AND NEW TECHNOLOGY (2009)
The impact of new drugs on US longevity and medical expenditure, 1990-2003: Evidence from longitudinal, disease-level data
Frank R. Lichtenberg
AMERICAN ECONOMIC REVIEW (2007)
Effects of new drugs on overall health spending: Frank Lichtenberg responds
Frank R. Lichtenberg
HEALTH AFFAIRS (2007)
The effect of new drug approvals on HIV mortality in the US, 1987-1998
Frank R. Lichtenberg
ECONOMICS & HUMAN BIOLOGY (2003)
分享论文
